New hope for hemophilia? first human trial tests potential Game-Changer
Disease control
Recruiting now
This is the first human study testing a new drug called SR604. Researchers want to see if it's safe and how it behaves in the body. First, healthy volunteers will receive single doses. Then, people with hemophilia A, hemophilia B, or Factor VII deficiency will receive multiple do…
Phase: PHASE1 • Sponsor: Equilibra Bioscience LLC • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC